NPC1L1 and gallstones: Since various Niemann-Pick C1-like 1 (NPC1L1) mutations have been found to increase biliary cholesterol concentrations, which in turn increases the risk of gallstone, the abundance of NPC1L1 proteins in the human liver is considered a plausible defense against gallstone (25).